The role of duodenal jejunal bypass liner in obesity treatment

Basit Öğe Kaydı
dc.authorid0000-0002-7751-9789en_US
dc.authorid0000-0003-3645-5579en_US
dc.authorid0000-0003-2324-6874en_US
dc.contributor.authorTayfur, Muhittin
dc.contributor.authorÖzcan, Çiğdem
dc.contributor.authorÇakıroğlu, Funda Pınar
dc.contributor.authorÜlger, Taha Gökmen
dc.date.accessioned2023-05-18T12:14:44Z
dc.date.available2023-05-18T12:14:44Z
dc.date.issued2021en_US
dc.departmentBAİBÜ, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümüen_US
dc.description.abstractEndoscopic bariatric procedures including Duedenal Jejunal Bypass Liner (DJBL) have become widespread in obesity treatment in recent years. The aim of this systematic review was to assess the role of DJBL in obesity treatment. A comprehensive search of several databases, including Cochrane Library, PubMed, and Web of Science was conducted to December 2020. Twenty-four clinical studies were assessed. According to the results, it is clear that DJBL provides effective weight reduction at 6-12 months and significant improvements in parameters associated with metabolic syndrome and cardiovascular disease. This technique also has potential to reduce comedications in patients with obesity and type 2 diabetes. Although these positive effects of DJBL are clear, its effect on liver, pancreatic functions, and inflammation markers are not clear yet. In addition, the overall and serious complication (gastrointestinal bleeds, pancreatitis, hepatic abscess, obstruction of the sleeve, biliary colic without cholecystitis and cholangitis) rate causing from the DJBL is very high. DJBL has not been approved by the Food and Drug Administration due to the frequency and severity of complications it causes. While it is certain that DJBL has significant effects on obesity and obesity related comorbidities, the safety aspect needs to be improved.en_US
dc.identifier.citationÜlger, T. G., Tayfur, M., Çakıroğlu, F. P., & Özcan, Ç. (2021). The role of duodenal jejunal bypass liner in obesity treatment. AIMS Medical Science, 8(3), 224-236.en_US
dc.identifier.doi10.3934/medsci.2021019
dc.identifier.endpage236en_US
dc.identifier.issn2375-1576
dc.identifier.issue3en_US
dc.identifier.startpage224en_US
dc.identifier.urihttp://dx.doi.org/10.3934/medsci.2021019
dc.identifier.urihttps://hdl.handle.net/20.500.12491/10918
dc.identifier.volume8en_US
dc.identifier.wosWOS:000707639100003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorÜlger, Taha Gökmen
dc.institutionauthorMuhittin, Tayfur
dc.language.isoenen_US
dc.publisherAMER INST MATHEMATICAL SCIENCES-AIMSen_US
dc.relation.ispartofAims Medical Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDuodenal Jejunal Bypass Lineren_US
dc.subjectDuodenal Jejunal Bypass Sleeveen_US
dc.subjectEndoBarrieren_US
dc.subjectWeight-Lossen_US
dc.subjectGlycemic Controlen_US
dc.subjectMetabolic Improvementen_US
dc.titleThe role of duodenal jejunal bypass liner in obesity treatmenten_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
taha-gokmen-ulger.pdf
Boyut:
751.57 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Beslenme ve Diyetetik Bölümü Koleksiyonu